CONMED Corp
CNMDUS売上高
$1.4B
百万USD
営業利益
$103M
百万USD
純利益
$47M
百万USD
ROE
4.6%
最新FY
EPS
$1.51
USD / 株
配当
$0.60
USD / 株
業績推移
収益性
キャッシュフロー
財務状況
四半期業績
| 年度 | 期 | 売上高 | 純利益 | EPS |
|---|---|---|---|---|
| FY2021 | Q1 | $233M | $10M | $0.31 |
| FY2021 | Q2 | $255M | $13M | $0.41 |
| FY2021 | Q3 | $249M | $15M | $0.47 |
| FY2021 | FY | $1.0B | $63M | $1.94 |
| FY2022 | Q1 | $242M | $15M | $0.47 |
| FY2022 | Q2 | $277M | $-168M | $-5.65 |
| FY2022 | Q3 | $275M | $46M | $1.48 |
| FY2022 | FY | $1.0B | $-81M | $-2.68 |
| FY2023 | Q1 | $295M | $2M | $0.06 |
| FY2023 | Q2 | $318M | $14M | $0.43 |
| FY2023 | Q3 | $305M | $16M | $0.50 |
| FY2023 | FY | $1.2B | $64M | $2.04 |
| FY2024 | Q1 | $312M | $20M | $0.63 |
| FY2024 | Q2 | $332M | $30M | $0.96 |
| FY2024 | Q3 | $317M | $49M | $1.57 |
| FY2024 | FY | $1.3B | $132M | $4.25 |
| FY2025 | Q1 | $321M | $6M | $0.19 |
| FY2025 | Q2 | $342M | $21M | $0.69 |
| FY2025 | Q3 | $338M | $3M | $0.09 |
| FY2025 | FY | $1.4B | $47M | $1.51 |
財務データ
| 指標 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| 売上高 | - | - | $860M | $955M | $862M | $1.0B | $1.0B | $1.2B | $1.3B | $1.4B |
| 営業利益 | $38M | $47M | $71M | $79M | $46M | $110M | $70M | $121M | $200M | $103M |
| 純利益 | $15M | $55M | $41M | $29M | $10M | $63M | $-81M | $64M | $132M | $47M |
| 総資産 | $1.3B | $1.4B | $1.4B | $1.8B | $1.8B | $1.8B | $2.3B | $2.3B | $2.3B | $2.3B |
| 純資産 | - | - | - | - | - | - | - | - | - | - |
| 自己資本 | $581M | $631M | $662M | $710M | $709M | $785M | $746M | $834M | $963M | $1.0B |
| 営業CF | $38M | $66M | $75M | $95M | $65M | $112M | $33M | $125M | $167M | $171M |
| EPS | $0.52 | $1.97 | $1.41 | $0.97 | $0.32 | $1.94 | $-2.68 | $2.04 | $4.25 | $1.51 |
| BPS | $20.86 | $22.57 | $23.53 | $24.94 | $24.50 | $26.71 | $24.44 | $27.10 | $31.15 | $33.51 |
| ROE | 2.5% | 8.8% | 6.2% | 4.0% | 1.3% | 8.0% | -10.8% | 7.7% | 13.8% | 4.6% |